GoodRx Holdings, Inc. GDRX Increase (Decrease) in Prescription Reimbursement Assets
Increase (Decrease) in Prescription Reimbursement Assets at other companies
Other financials
Where this comes from
Reported directly by GoodRx Holdings, Inc. in its filing.
Tagged under the XBRL concept gdrx:IncreaseDecreaseInPrescriptionReimbursementAssets.
The official record: GoodRx Holdings, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about GoodRx Holdings, Inc.'s increase (decrease) in prescription reimbursement assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is GoodRx Holdings, Inc.'s increase (decrease) in prescription reimbursement assets?
- GoodRx Holdings, Inc. (GDRX) reported increase (decrease) in prescription reimbursement assets of $655.2M in Q1 2026.
- How has GoodRx Holdings, Inc.'s increase (decrease) in prescription reimbursement assets changed year-over-year?
- GoodRx Holdings, Inc.'s increase (decrease) in prescription reimbursement assets increased by 4452.8% year-over-year, from $14.39M to $655.2M.
- What does increase (decrease) in prescription reimbursement assets mean?
- This tracks the net change in assets related to prescription reimbursement claims that are pending collection from pharmacy benefit managers or other payers. Fluctuations in this balance highlight changes in the timing of cash inflows and potential credit risk associated with the company's primary revenue partners.